Methods for monitoring patients with severe sepsis and septic shock and for selecting treatments for these patients

• 1. 早期检测败血症及检测败血症的严重程度并对败血症病程进行跟踪评估的方法，以及实现所述方法的药盒 [P] . 中国专利： CN1090928A . 1994-08-17
• 2. 包含新琼寡糖作为有效成分的败血症或败血症性休克的预防或治疗用药学组合物 [P] . 中国专利： CN107206018B . 2020.06.26
• 3. METHODS FOR MONITORING PATIENTS WITH SEVERE SEPSIS AND SEPTIC SHOCK AND FOR SELECTING TREATMENTS FOR THESE PATIENTS [P] . 世界知识产权组织专利： WO2009120823A1 . 2009-10-01

  机译： 监测患有严重脓毒症和脓毒症的患者以及为这些患者选择治疗方法的方法

• 4. Method and kit for rapidly determining patients with severe risk of death during severe sepsis and septic shock [P] . 日本专利： JP5619016B2 . 2014-11-05

  机译： 快速确定严重败血症和败血性休克中有严重死亡危险的患者的方法和试剂盒

• 5. METHODS AND KITS FOR THE RAPID DETERMINATION OF PATIENTS AT HIGH RISK OF DEATH DURING SEVERE SEPSIS AND SEPTIC SHOCK [P] . 欧洲知识产权局专利： EP2350646B1 . 2016-01-13

  机译： 严重脓毒症和震荡发作高危死亡患者的快速测定方法和试剂盒

• 1. Outcomes of severe sepsis and septic shock patients after stratifi cation by initial lactate value [J] . Kimberly A. Chambers, Adam Y. Park, Rosa C. Banuelos, 世界急诊医学杂志(英文版) . 2018,第002期
• 2. Outcomes of severe sepsis and septic shock patients after stratification by initial lactate value [J] . Kimberly A. Chambers, Adam Y. Park, Rosa C. Banuelos, 世界急诊医学杂志（英文） . 2018,第002期
• 3. Raoultella planticolaBacteremia-Induced Fatal Septic Shock and Sepsis-Induced Coagulopathy in a Patient with Pancreatic Cancer: A Case Report and Literature Review [J] . Konul Hajiyeva, Mehmet Oral 临床医学国际期刊（英文） . 2021,第001期
• 4. Outcomes in severe sepsis and patients with septic shock do not matter! PIRO is a score to treat severe septic and septic shock patients not to measure outcomes. [J] . Rubulotta F, Ramsay G Critical care medicine . 2012,第2期
• 5. The utilization of the surviving sepsis campaign care bundles in the treatment of pediatric patients with severe sepsis or septic shock in a resource-limited environment: A prospective multicenter trial [J] . Rujipat Samransamruajkit, Kawiwan Limprayoon, Rojanee Lertbunrian, Indian Journal of Critical Care Medicine . 2018,第12期
• 6. Calibrated versus uncalibrated arterial pressure waveform analysis in monitoring cardiac output with transpulmonary thermodilution in patients with severe sepsis and septic shock An observational study [J] . Slagt Cornelis, Helmi Mochamat, Malagon Ignacio, European journal of anaesthesiology . 2015,第1期
• 7. Relation of heart rate variability to serum levels of C-reactive protein in patients with severe sepsis and septic shock [C] . Papaioannou V.P., Dragoumanis C.D., Pneumatikos I.P. Computers in Cardiology, 2009 . 2009
• 8. Utilizing a multi-faceted approach to improve 6-hour bundle compliance of patients with severe sepsis and septic shock [D] . Gabbard, Erika 2015
• 9. Early Infectious Disease Consultation Is Associated With Lower Mortality in Patients With Severe Sepsis or Septic Shock Who Complete the 3-Hour Sepsis Treatment Bundle [O] . Theresa Madaline, Francis Wadskier Montagne, Ruth Eisenberg, 2019
• 10. Clinical pathway intervention compliance and effectiveness when used in the treatment of patients with severe sepsis and septic shock at an Intensive Care Unit in Spain Cumplimiento y efectividad de las intervenciones de un protocolo clínico utilizado en pacientes con sepsis grave y shock séptico en una Unidad de Cuidados Intensivos en España Observância e efetividade das intervenções de um protocolo clínico utilizado para pacientes com sepse grave e choque séptico de uma Unidade de Cuidados Intensivos da Espanha [O] . Ana Laguna-Pérez, Elisa Chilet-Rosell, Miguel Delgado Lacosta, 2012

• 1. Blood glucose control in patients with severe sepsis and septic shock [J] . Hiroyuki Hirasawa ,Shigeto Oda ,Masataka Nakamura . 世界胃肠病学杂志：英文版 . 2009,第33期
• 2. Severe insulin resistance treatment with intravenous chromium in septic shock patient [J] . Salim R Surani ,Iqbal Ratnani ,Bharath Guntupalli . 世界糖尿病杂志：英文版（电子版） . 2012,第9期
• 3. 严重感染和感染性休克患者液体复苏的胶体液选择 [C] . . 第九次全国麻醉学与复苏进展学术会议 . 2013
• 4. 基于真实世界数据和PK/PD模型引导的β--内酰胺类药物在新生儿败血症患者中的群体药代动力学、有效性和安全性研究 [A] . 吴月娥 . 2021